Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

CARBIDOPA Drug Profile

« Back to Dashboard

What is the patent landscape for Carbidopa, and what generic alternatives are available?

Carbidopa is a drug marketed by Edenbridge Pharms, Amerigen Pharms Ltd, Alvogen Malta, Mayne Pharma, Apotex, Apotex Inc, Idt Australia Ltd, Impax Labs, Accord Hlthcare, Mylan, Sun Pharm Inds, Actavis Elizabeth, Kv Pharm, SCS, Watson Labs, Sun Pharma Global, and Wockhardt Ltd. and is included in twenty-nine NDAs.

The generic ingredient in CARBIDOPA is carbidopa; entacapone; levodopa. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the carbidopa; entacapone; levodopa profile page.

Summary for Tradename: CARBIDOPA

Suppliers / Packagers: see list4
Bulk Api Vendors: see list46
Clinical Trials: see list70
Patent Applications: see list3,653
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARBIDOPA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
carbidopa; levodopa
TABLET, ORALLY DISINTEGRATING;ORAL078690-002Jul 31, 2009ABRXNoNo► Subscribe► Subscribe
carbidopa; levodopa
TABLET;ORAL074080-002Mar 25, 1994DISCNNoNo► Subscribe► Subscribe
Wockhardt Ltd
carbidopa; entacapone; levodopa
TABLET;ORAL090833-002Nov 20, 2012ABRXNoNo► Subscribe► Subscribe
carbidopa; levodopa
TABLET, ORALLY DISINTEGRATING;ORAL078893-001Sep 18, 2008ABRXNoNo► Subscribe► Subscribe
Wockhardt Ltd
carbidopa; entacapone; levodopa
TABLET;ORAL090833-003Nov 20, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus